Account
Inquiry
Tirzepatide 20mg is a dual GIP and GLP-1 receptor agonist that has shown significant potential in metabolic research applications. This synthetic peptide demonstrates superior stability and biological activity, making it particularly valuable for scientific studies.
The 20mg formulation offers researchers precise dosing capabilities for various experimental protocols. With 99.7% purity confirmed by HPLC analysis, this product meets the stringent requirements of laboratory research. Each batch comes with complete analytical documentation including COA.
As a pharmaceutical intermediate, Tirzepatide 20mg is supplied in lyophilized powder form for enhanced stability. The product is carefully packaged to maintain integrity during storage and transport. Research applications include metabolic studies, receptor binding assays, and pharmacological investigations.
Our manufacturing process follows strict quality control protocols to ensure batch-to-batch consistency. The product is synthesized under cGMP conditions and undergoes comprehensive analytical testing. For research use only, not for human consumption.
Tirzepatide 20mg represents an important tool for researchers studying metabolic pathways and peptide therapeutics. The dual agonist activity makes it particularly interesting for comparative studies with single-receptor agonists. Proper storage at controlled temperatures is recommended to maintain product stability.
